Georgina Eden

Georgina completed her Honours at The University of Adelaide working on developing novel therapies for the adverse side effects of chemotherapy on the gastrointestinal tract. She then worked at the Children’s Cancer Institute in Sydney for 4 years where she assisted in discovering new therapeutic approaches for the treatment of Neuroblastoma (most common extracranial solid tumour in children). During her time at the Children’s Cancer Institute she was involved in the Zero Childhood Cancer national clinical trial. This trial aims to develop personalised cancer treatment strategies for children, throughout Australia, with high-risk or relapsed cancer.

In mid-2018, Georgina returned to Adelaide to work as an EMBL Australia Laboratory Manager and Research Officer in David Lynn’s Computational and Systems Biology Program, part of the Precision Medicine Theme at SAHMRI. She is assisting in projects investigating the interplay between the microbiota and the immune system.